Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control

PURPOSE: Combining radiotherapy (RT) with DNA damage response inhibitors may lead to increased tumor cell death through radiosensitization. DNA-dependent protein kinase (DNA-PK) plays an important role in DNA double-strand break repair via the nonhomologous end joining (NHEJ) pathway. We hypothesize...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kyoko, Karmokar, Ankur, Farrington, Paul M., James, Neil H., Ramos-Montoya, Antonio, Bickerton, Susan J., Hughes, Gareth D., Illidge, Timothy M., Cadogan, Elaine B., Davies, Barry R., Dovedi, Simon J., Valge-Archer, Viia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401489/
https://www.ncbi.nlm.nih.gov/pubmed/34011558
http://dx.doi.org/10.1158/1078-0432.CCR-20-3701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401489/
https://www.ncbi.nlm.nih.gov/pubmed/34011558
http://dx.doi.org/10.1158/1078-0432.CCR-20-3701

Ejemplares similares